Proceedings: Cultured lymphoblastoid lines as a model for leukaemia/lymphoma.

por Steel, C. M.
Publicado 1975

Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

por Thompson, A. M., Kerr, D. J., Steel, C. M.
Publicado 1991

Cancer risk perceptions and distress among women attending a familial ovarian cancer clinic

por Cull, A, Fry, A, Rush, R, Steel, C M
Publicado 2001

Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies.

por Busby-Earle, R. M., Steel, C. M., Bird, C. C.
Publicado 1993

High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

por Devlin, J., Elder, P. A., Gabra, H., Steel, C. M., Knowles, M. A.
Publicado 1996

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.

por Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., Steel, C. M.
Publicado 1998

p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.

por Busby-Earle, R. M., Steel, C. M., Williams, A. R., Cohen, B., Bird, C. C.
Publicado 1994

Mutations in p53 do not account for heritable breast cancer: a study in five affected families.

por Prosser, J., Elder, P. A., Condie, A., MacFadyen, I., Steel, C. M., Evans, H. J.
Publicado 1991

The use of videotaped information in cancer genetic counselling: a randomized evaluation study.

por Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E. D., Steel, C. M., Elton, R. A.
Publicado 1998

pS2 is an independent factor of good prognosis in primary breast cancer.

por Thompson, A. M., Hawkins, R. A., Elton, R. A., Steel, C. M., Chetty, U., Carter, D. C.
Publicado 1993

Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

por Thompson, A. M., Morris, R. G., Wallace, M., Wyllie, A. H., Steel, C. M., Carter, D. C.
Publicado 1993

Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

por Eccles, D. M., Brett, L., Lessells, A., Gruber, L., Lane, D., Steel, C. M., Leonard, R. C.
Publicado 1992

Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression.

por Wyllie, A. H., Rose, K. A., Morris, R. G., Steel, C. M., Foster, E., Spandidos, D. A.
Publicado 1987

Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines.

por Bird, C. C., Waddell, A. W., Robertson, A. M., Currie, A. R., Steel, C. M., Evans, J.
Publicado 1975

Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up...

por Thompson, A. M., Crichton, D. N., Elton, R. A., Clay, M. F., Chetty, U., Steel, C. M.
Publicado 1998

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.

por Prosser, J., Porter, D., Coles, C., Condie, A., Thompson, A. M., Chetty, U., Steel, C. M., Evans, H. J.
Publicado 1992

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

por Mackay, J., Elder, P. A., Porteous, D. J., Steel, C. M., Hawkins, R. A., Going, J. J., Chetty, U.
Publicado 1988

Chromosomal radiosensitivity in G(2)-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics

por Riches, A C, Bryant, P E, Steel, C M, Gleig, A, Robertson, A J, Preece, P E, Thompson, A M
Publicado 2001

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

por Gabra, H., Taylor, L., Cohen, B. B., Lessels, A., Eccles, D. M., Leonard, R. C., Smyth, J. F., Steel, C. M.
Publicado 1995

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.

por Thompson, A. M., Steel, C. M., Chetty, U., Hawkins, R. A., Miller, W. R., Carter, D. C., Forrest, A. P., Evans, H. J.
Publicado 1990